nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylergometrine—CYP3A4—Pilocarpine—glaucoma	0.0731	0.236	CbGbCtD
Methylergometrine—CYP3A4—Brinzolamide—glaucoma	0.0574	0.185	CbGbCtD
Methylergometrine—CYP3A4—Dorzolamide—glaucoma	0.0554	0.178	CbGbCtD
Methylergometrine—CYP3A4—Methazolamide—glaucoma	0.0494	0.159	CbGbCtD
Methylergometrine—CYP3A4—Acetazolamide—glaucoma	0.0395	0.127	CbGbCtD
Methylergometrine—CYP3A4—Clonidine—glaucoma	0.0357	0.115	CbGbCtD
Methylergometrine—Nasal congestion—Clonidine—glaucoma	0.00307	0.00499	CcSEcCtD
Methylergometrine—Angina pectoris—Brinzolamide—glaucoma	0.00307	0.00498	CcSEcCtD
Methylergometrine—Dyspnoea—Metipranolol—glaucoma	0.00305	0.00496	CcSEcCtD
Methylergometrine—Convulsion—Methazolamide—glaucoma	0.00305	0.00495	CcSEcCtD
Methylergometrine—Haematuria—Acetazolamide—glaucoma	0.00297	0.00482	CcSEcCtD
Methylergometrine—Hypotension—Carteolol—glaucoma	0.00296	0.00481	CcSEcCtD
Methylergometrine—Angina pectoris—Pilocarpine—glaucoma	0.00295	0.00479	CcSEcCtD
Methylergometrine—Hyperhidrosis—Carbachol—glaucoma	0.00294	0.00478	CcSEcCtD
Methylergometrine—Chest pain—Latanoprost—glaucoma	0.0029	0.00471	CcSEcCtD
Methylergometrine—Anaphylactic shock—Methazolamide—glaucoma	0.00287	0.00466	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Clonidine—glaucoma	0.00285	0.00463	CcSEcCtD
Methylergometrine—Hypotension—Carbachol—glaucoma	0.00284	0.00462	CcSEcCtD
Methylergometrine—Dyspnoea—Carteolol—glaucoma	0.00283	0.00459	CcSEcCtD
Methylergometrine—Atrioventricular block—Timolol—glaucoma	0.00282	0.00459	CcSEcCtD
Methylergometrine—Thrombophlebitis—Betaxolol—glaucoma	0.00281	0.00457	CcSEcCtD
Methylergometrine—Hypotension—Levobunolol—glaucoma	0.0028	0.00455	CcSEcCtD
Methylergometrine—Paraesthesia—Diclofenamide—glaucoma	0.0028	0.00455	CcSEcCtD
Methylergometrine—Bradycardia—Brimonidine—glaucoma	0.00273	0.00444	CcSEcCtD
Methylergometrine—Nervous system disorder—Latanoprost—glaucoma	0.00272	0.00443	CcSEcCtD
Methylergometrine—Paraesthesia—Levobunolol—glaucoma	0.00269	0.00437	CcSEcCtD
Methylergometrine—Dyspnoea—Levobunolol—glaucoma	0.00267	0.00434	CcSEcCtD
Methylergometrine—Bradycardia—Dorzolamide—glaucoma	0.00261	0.00424	CcSEcCtD
Methylergometrine—Tinnitus—Acetazolamide—glaucoma	0.00261	0.00424	CcSEcCtD
Methylergometrine—Bradycardia—Travoprost—glaucoma	0.0026	0.00422	CcSEcCtD
Methylergometrine—Paraesthesia—Methazolamide—glaucoma	0.00258	0.00419	CcSEcCtD
Methylergometrine—Haematuria—Pilocarpine—glaucoma	0.00257	0.00418	CcSEcCtD
Methylergometrine—Bradycardia—Brinzolamide—glaucoma	0.00256	0.00417	CcSEcCtD
Methylergometrine—Hallucination—Dorzolamide—glaucoma	0.00255	0.00414	CcSEcCtD
Methylergometrine—Cardiac disorder—Brimonidine—glaucoma	0.00249	0.00405	CcSEcCtD
Methylergometrine—Dyspnoea—Latanoprost—glaucoma	0.00248	0.00402	CcSEcCtD
Methylergometrine—Bradycardia—Pilocarpine—glaucoma	0.00246	0.00401	CcSEcCtD
Methylergometrine—Abdominal pain—Carbachol—glaucoma	0.0024	0.00391	CcSEcCtD
Methylergometrine—Palpitations—Apraclonidine—glaucoma	0.0024	0.00391	CcSEcCtD
Methylergometrine—Tinnitus—Dorzolamide—glaucoma	0.00239	0.00388	CcSEcCtD
Methylergometrine—Tinnitus—Travoprost—glaucoma	0.00238	0.00387	CcSEcCtD
Methylergometrine—Cardiac disorder—Travoprost—glaucoma	0.00237	0.00385	CcSEcCtD
Methylergometrine—Tinnitus—Brinzolamide—glaucoma	0.00235	0.00382	CcSEcCtD
Methylergometrine—Cardiac disorder—Brinzolamide—glaucoma	0.00234	0.0038	CcSEcCtD
Methylergometrine—Palpitations—Bimatoprost—glaucoma	0.00233	0.00379	CcSEcCtD
Methylergometrine—Chest pain—Apraclonidine—glaucoma	0.00232	0.00376	CcSEcCtD
Methylergometrine—Hypertension—Bimatoprost—glaucoma	0.00228	0.0037	CcSEcCtD
Methylergometrine—Dizziness—Metipranolol—glaucoma	0.00226	0.00368	CcSEcCtD
Methylergometrine—Tinnitus—Pilocarpine—glaucoma	0.00226	0.00367	CcSEcCtD
Methylergometrine—Chest pain—Bimatoprost—glaucoma	0.00225	0.00365	CcSEcCtD
Methylergometrine—Nasal congestion—Timolol—glaucoma	0.00218	0.00355	CcSEcCtD
Methylergometrine—Nervous system disorder—Apraclonidine—glaucoma	0.00218	0.00354	CcSEcCtD
Methylergometrine—Rash—Metipranolol—glaucoma	0.00216	0.00351	CcSEcCtD
Methylergometrine—Dermatitis—Metipranolol—glaucoma	0.00216	0.0035	CcSEcCtD
Methylergometrine—Headache—Metipranolol—glaucoma	0.00214	0.00348	CcSEcCtD
Methylergometrine—Nervous system disorder—Bimatoprost—glaucoma	0.00211	0.00343	CcSEcCtD
Methylergometrine—Convulsion—Acetazolamide—glaucoma	0.00211	0.00343	CcSEcCtD
Methylergometrine—Muscle spasms—Brinzolamide—glaucoma	0.00211	0.00343	CcSEcCtD
Methylergometrine—Dizziness—Carteolol—glaucoma	0.0021	0.00341	CcSEcCtD
Methylergometrine—Diarrhoea—Carbachol—glaucoma	0.00208	0.00338	CcSEcCtD
Methylergometrine—Palpitations—Brimonidine—glaucoma	0.00206	0.00335	CcSEcCtD
Methylergometrine—Dizziness—Diclofenamide—glaucoma	0.00206	0.00335	CcSEcCtD
Methylergometrine—Diarrhoea—Levobunolol—glaucoma	0.00205	0.00333	CcSEcCtD
Methylergometrine—Angina pectoris—Betaxolol—glaucoma	0.00205	0.00333	CcSEcCtD
Methylergometrine—Nausea—Metipranolol—glaucoma	0.00203	0.0033	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Timolol—glaucoma	0.00203	0.0033	CcSEcCtD
Methylergometrine—Muscle spasms—Pilocarpine—glaucoma	0.00203	0.00329	CcSEcCtD
Methylergometrine—Hypertension—Brimonidine—glaucoma	0.00202	0.00328	CcSEcCtD
Methylergometrine—Dizziness—Carbachol—glaucoma	0.00201	0.00327	CcSEcCtD
Methylergometrine—Paraesthesia—Apraclonidine—glaucoma	0.00199	0.00324	CcSEcCtD
Methylergometrine—Chest pain—Brimonidine—glaucoma	0.00199	0.00323	CcSEcCtD
Methylergometrine—Anaphylactic shock—Acetazolamide—glaucoma	0.00199	0.00323	CcSEcCtD
Methylergometrine—Headache—Carteolol—glaucoma	0.00199	0.00323	CcSEcCtD
Methylergometrine—Vomiting—Diclofenamide—glaucoma	0.00198	0.00322	CcSEcCtD
Methylergometrine—Dizziness—Levobunolol—glaucoma	0.00198	0.00322	CcSEcCtD
Methylergometrine—Dyspnoea—Apraclonidine—glaucoma	0.00198	0.00322	CcSEcCtD
Methylergometrine—Palpitations—Dorzolamide—glaucoma	0.00197	0.0032	CcSEcCtD
Methylergometrine—Bradycardia—Clonidine—glaucoma	0.00197	0.0032	CcSEcCtD
Methylergometrine—Rash—Diclofenamide—glaucoma	0.00196	0.00319	CcSEcCtD
Methylergometrine—Diarrhoea—Methazolamide—glaucoma	0.00196	0.00319	CcSEcCtD
Methylergometrine—Palpitations—Travoprost—glaucoma	0.00196	0.00319	CcSEcCtD
Methylergometrine—Headache—Diclofenamide—glaucoma	0.00195	0.00317	CcSEcCtD
Methylergometrine—Palpitations—Brinzolamide—glaucoma	0.00194	0.00315	CcSEcCtD
Methylergometrine—Vomiting—Carbachol—glaucoma	0.00193	0.00314	CcSEcCtD
Methylergometrine—Hypertension—Dorzolamide—glaucoma	0.00193	0.00313	CcSEcCtD
Methylergometrine—Hallucination—Clonidine—glaucoma	0.00192	0.00313	CcSEcCtD
Methylergometrine—Dyspnoea—Bimatoprost—glaucoma	0.00192	0.00312	CcSEcCtD
Methylergometrine—Rash—Carbachol—glaucoma	0.00192	0.00312	CcSEcCtD
Methylergometrine—Hypertension—Travoprost—glaucoma	0.00192	0.00312	CcSEcCtD
Methylergometrine—Dermatitis—Carbachol—glaucoma	0.00192	0.00311	CcSEcCtD
Methylergometrine—Headache—Carbachol—glaucoma	0.00191	0.0031	CcSEcCtD
Methylergometrine—Chest pain—Dorzolamide—glaucoma	0.0019	0.00309	CcSEcCtD
Methylergometrine—Hypertension—Brinzolamide—glaucoma	0.00189	0.00308	CcSEcCtD
Methylergometrine—Chest pain—Travoprost—glaucoma	0.00189	0.00307	CcSEcCtD
Methylergometrine—Nausea—Carteolol—glaucoma	0.00188	0.00306	CcSEcCtD
Methylergometrine—Headache—Levobunolol—glaucoma	0.00188	0.00305	CcSEcCtD
Methylergometrine—Nervous system disorder—Brimonidine—glaucoma	0.00187	0.00304	CcSEcCtD
Methylergometrine—Chest pain—Brinzolamide—glaucoma	0.00187	0.00303	CcSEcCtD
Methylergometrine—Palpitations—Pilocarpine—glaucoma	0.00186	0.00303	CcSEcCtD
Methylergometrine—Tachycardia—Brimonidine—glaucoma	0.00186	0.00302	CcSEcCtD
Methylergometrine—Nausea—Diclofenamide—glaucoma	0.00185	0.00301	CcSEcCtD
Methylergometrine—Dizziness—Latanoprost—glaucoma	0.00184	0.00298	CcSEcCtD
Methylergometrine—Vomiting—Methazolamide—glaucoma	0.00182	0.00296	CcSEcCtD
Methylergometrine—Anaphylactic shock—Dorzolamide—glaucoma	0.00182	0.00296	CcSEcCtD
Methylergometrine—Hypertension—Pilocarpine—glaucoma	0.00182	0.00296	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Apraclonidine—glaucoma	0.00182	0.00295	CcSEcCtD
Methylergometrine—Rash—Methazolamide—glaucoma	0.00181	0.00294	CcSEcCtD
Methylergometrine—Dermatitis—Methazolamide—glaucoma	0.00181	0.00294	CcSEcCtD
Methylergometrine—Nausea—Carbachol—glaucoma	0.00181	0.00294	CcSEcCtD
Methylergometrine—Tinnitus—Clonidine—glaucoma	0.0018	0.00293	CcSEcCtD
Methylergometrine—Headache—Methazolamide—glaucoma	0.0018	0.00292	CcSEcCtD
Methylergometrine—Cardiac disorder—Clonidine—glaucoma	0.00179	0.00292	CcSEcCtD
Methylergometrine—Chest pain—Pilocarpine—glaucoma	0.00179	0.00292	CcSEcCtD
Methylergometrine—Paraesthesia—Acetazolamide—glaucoma	0.00178	0.0029	CcSEcCtD
Methylergometrine—Hypotension—Brimonidine—glaucoma	0.00178	0.00289	CcSEcCtD
Methylergometrine—Nausea—Levobunolol—glaucoma	0.00178	0.00289	CcSEcCtD
Methylergometrine—Nervous system disorder—Travoprost—glaucoma	0.00178	0.00289	CcSEcCtD
Methylergometrine—Tachycardia—Travoprost—glaucoma	0.00177	0.00287	CcSEcCtD
Methylergometrine—Hyperhidrosis—Dorzolamide—glaucoma	0.00176	0.00286	CcSEcCtD
Methylergometrine—Abdominal pain—Apraclonidine—glaucoma	0.00176	0.00285	CcSEcCtD
Methylergometrine—Nervous system disorder—Brinzolamide—glaucoma	0.00176	0.00285	CcSEcCtD
Methylergometrine—Rash—Latanoprost—glaucoma	0.00175	0.00285	CcSEcCtD
Methylergometrine—Dermatitis—Latanoprost—glaucoma	0.00175	0.00284	CcSEcCtD
Methylergometrine—Tachycardia—Brinzolamide—glaucoma	0.00175	0.00284	CcSEcCtD
Methylergometrine—Headache—Latanoprost—glaucoma	0.00174	0.00283	CcSEcCtD
Methylergometrine—Bradycardia—Betaxolol—glaucoma	0.00171	0.00278	CcSEcCtD
Methylergometrine—Paraesthesia—Brimonidine—glaucoma	0.00171	0.00278	CcSEcCtD
Methylergometrine—Nausea—Methazolamide—glaucoma	0.0017	0.00277	CcSEcCtD
Methylergometrine—Hypotension—Dorzolamide—glaucoma	0.0017	0.00276	CcSEcCtD
Methylergometrine—Dyspnoea—Brimonidine—glaucoma	0.0017	0.00276	CcSEcCtD
Methylergometrine—Hypotension—Travoprost—glaucoma	0.00169	0.00275	CcSEcCtD
Methylergometrine—Tachycardia—Pilocarpine—glaucoma	0.00168	0.00273	CcSEcCtD
Methylergometrine—Hallucination—Betaxolol—glaucoma	0.00167	0.00272	CcSEcCtD
Methylergometrine—Angina pectoris—Timolol—glaucoma	0.00167	0.00272	CcSEcCtD
Methylergometrine—Hypotension—Brinzolamide—glaucoma	0.00167	0.00272	CcSEcCtD
Methylergometrine—Hyperhidrosis—Pilocarpine—glaucoma	0.00166	0.0027	CcSEcCtD
Methylergometrine—Paraesthesia—Dorzolamide—glaucoma	0.00163	0.00266	CcSEcCtD
Methylergometrine—Dyspnoea—Dorzolamide—glaucoma	0.00162	0.00264	CcSEcCtD
Methylergometrine—Muscle spasms—Clonidine—glaucoma	0.00162	0.00263	CcSEcCtD
Methylergometrine—Dyspnoea—Travoprost—glaucoma	0.00162	0.00263	CcSEcCtD
Methylergometrine—Hypotension—Pilocarpine—glaucoma	0.00161	0.00261	CcSEcCtD
Methylergometrine—Paraesthesia—Brinzolamide—glaucoma	0.00161	0.00261	CcSEcCtD
Methylergometrine—Dyspnoea—Brinzolamide—glaucoma	0.0016	0.00259	CcSEcCtD
Methylergometrine—Tinnitus—Betaxolol—glaucoma	0.00157	0.00255	CcSEcCtD
Methylergometrine—Cardiac disorder—Betaxolol—glaucoma	0.00156	0.00254	CcSEcCtD
Methylergometrine—Paraesthesia—Pilocarpine—glaucoma	0.00154	0.00251	CcSEcCtD
Methylergometrine—Dyspnoea—Pilocarpine—glaucoma	0.00153	0.00249	CcSEcCtD
Methylergometrine—Diarrhoea—Apraclonidine—glaucoma	0.00152	0.00247	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Dorzolamide—glaucoma	0.00149	0.00242	CcSEcCtD
Methylergometrine—Palpitations—Clonidine—glaucoma	0.00149	0.00242	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Travoprost—glaucoma	0.00148	0.00241	CcSEcCtD
Methylergometrine—Dizziness—Apraclonidine—glaucoma	0.00147	0.00239	CcSEcCtD
Methylergometrine—Abdominal pain—Dorzolamide—glaucoma	0.00144	0.00234	CcSEcCtD
Methylergometrine—Chest pain—Clonidine—glaucoma	0.00143	0.00233	CcSEcCtD
Methylergometrine—Abdominal pain—Travoprost—glaucoma	0.00143	0.00233	CcSEcCtD
Methylergometrine—Dizziness—Bimatoprost—glaucoma	0.00142	0.00231	CcSEcCtD
Methylergometrine—Vomiting—Apraclonidine—glaucoma	0.00141	0.00229	CcSEcCtD
Methylergometrine—Muscle spasms—Betaxolol—glaucoma	0.00141	0.00229	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Pilocarpine—glaucoma	0.00141	0.00229	CcSEcCtD
Methylergometrine—Bradycardia—Timolol—glaucoma	0.0014	0.00227	CcSEcCtD
Methylergometrine—Dermatitis—Apraclonidine—glaucoma	0.0014	0.00227	CcSEcCtD
Methylergometrine—Headache—Apraclonidine—glaucoma	0.00139	0.00226	CcSEcCtD
Methylergometrine—Hallucination—Timolol—glaucoma	0.00137	0.00222	CcSEcCtD
Methylergometrine—Abdominal pain—Pilocarpine—glaucoma	0.00136	0.00221	CcSEcCtD
Methylergometrine—Diarrhoea—Acetazolamide—glaucoma	0.00136	0.00221	CcSEcCtD
Methylergometrine—Rash—Bimatoprost—glaucoma	0.00136	0.00221	CcSEcCtD
Methylergometrine—Dermatitis—Bimatoprost—glaucoma	0.00136	0.0022	CcSEcCtD
Methylergometrine—Headache—Bimatoprost—glaucoma	0.00135	0.00219	CcSEcCtD
Methylergometrine—Nervous system disorder—Clonidine—glaucoma	0.00135	0.00219	CcSEcCtD
Methylergometrine—Tachycardia—Clonidine—glaucoma	0.00134	0.00218	CcSEcCtD
Methylergometrine—Hyperhidrosis—Clonidine—glaucoma	0.00133	0.00216	CcSEcCtD
Methylergometrine—Nausea—Apraclonidine—glaucoma	0.00132	0.00214	CcSEcCtD
Methylergometrine—Dizziness—Acetazolamide—glaucoma	0.00131	0.00213	CcSEcCtD
Methylergometrine—Palpitations—Betaxolol—glaucoma	0.00129	0.0021	CcSEcCtD
Methylergometrine—Hypotension—Clonidine—glaucoma	0.00128	0.00209	CcSEcCtD
Methylergometrine—Tinnitus—Timolol—glaucoma	0.00128	0.00208	CcSEcCtD
Methylergometrine—Nausea—Bimatoprost—glaucoma	0.00128	0.00208	CcSEcCtD
Methylergometrine—Cardiac disorder—Timolol—glaucoma	0.00128	0.00207	CcSEcCtD
Methylergometrine—Vomiting—Acetazolamide—glaucoma	0.00126	0.00205	CcSEcCtD
Methylergometrine—Dizziness—Brimonidine—glaucoma	0.00126	0.00205	CcSEcCtD
Methylergometrine—Chest pain—Betaxolol—glaucoma	0.00125	0.00203	CcSEcCtD
Methylergometrine—Diarrhoea—Dorzolamide—glaucoma	0.00125	0.00202	CcSEcCtD
Methylergometrine—Headache—Acetazolamide—glaucoma	0.00124	0.00202	CcSEcCtD
Methylergometrine—Diarrhoea—Travoprost—glaucoma	0.00124	0.00202	CcSEcCtD
Methylergometrine—Paraesthesia—Clonidine—glaucoma	0.00123	0.002	CcSEcCtD
Methylergometrine—Dyspnoea—Clonidine—glaucoma	0.00122	0.00199	CcSEcCtD
Methylergometrine—Diarrhoea—Brinzolamide—glaucoma	0.00122	0.00199	CcSEcCtD
Methylergometrine—Dizziness—Dorzolamide—glaucoma	0.0012	0.00196	CcSEcCtD
Methylergometrine—Rash—Brimonidine—glaucoma	0.0012	0.00195	CcSEcCtD
Methylergometrine—Dermatitis—Brimonidine—glaucoma	0.0012	0.00195	CcSEcCtD
Methylergometrine—Dizziness—Travoprost—glaucoma	0.0012	0.00195	CcSEcCtD
Methylergometrine—Headache—Brimonidine—glaucoma	0.00119	0.00194	CcSEcCtD
Methylergometrine—Dizziness—Brinzolamide—glaucoma	0.00118	0.00192	CcSEcCtD
Methylergometrine—Nausea—Acetazolamide—glaucoma	0.00118	0.00192	CcSEcCtD
Methylergometrine—Diarrhoea—Pilocarpine—glaucoma	0.00118	0.00191	CcSEcCtD
Methylergometrine—Nervous system disorder—Betaxolol—glaucoma	0.00117	0.00191	CcSEcCtD
Methylergometrine—Tachycardia—Betaxolol—glaucoma	0.00117	0.0019	CcSEcCtD
Methylergometrine—Vomiting—Dorzolamide—glaucoma	0.00116	0.00188	CcSEcCtD
Methylergometrine—Hyperhidrosis—Betaxolol—glaucoma	0.00116	0.00188	CcSEcCtD
Methylergometrine—Rash—Dorzolamide—glaucoma	0.00115	0.00187	CcSEcCtD
Methylergometrine—Dermatitis—Dorzolamide—glaucoma	0.00115	0.00186	CcSEcCtD
Methylergometrine—Rash—Travoprost—glaucoma	0.00114	0.00186	CcSEcCtD
Methylergometrine—Dermatitis—Travoprost—glaucoma	0.00114	0.00186	CcSEcCtD
Methylergometrine—Headache—Dorzolamide—glaucoma	0.00114	0.00185	CcSEcCtD
Methylergometrine—Vomiting—Brinzolamide—glaucoma	0.00114	0.00185	CcSEcCtD
Methylergometrine—Dizziness—Pilocarpine—glaucoma	0.00114	0.00185	CcSEcCtD
Methylergometrine—Headache—Travoprost—glaucoma	0.00114	0.00185	CcSEcCtD
Methylergometrine—Nausea—Brimonidine—glaucoma	0.00113	0.00184	CcSEcCtD
Methylergometrine—Rash—Brinzolamide—glaucoma	0.00113	0.00183	CcSEcCtD
Methylergometrine—Dermatitis—Brinzolamide—glaucoma	0.00113	0.00183	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Clonidine—glaucoma	0.00112	0.00183	CcSEcCtD
Methylergometrine—Headache—Brinzolamide—glaucoma	0.00112	0.00182	CcSEcCtD
Methylergometrine—Hypotension—Betaxolol—glaucoma	0.00112	0.00182	CcSEcCtD
Methylergometrine—Vomiting—Pilocarpine—glaucoma	0.00109	0.00178	CcSEcCtD
Methylergometrine—Abdominal pain—Clonidine—glaucoma	0.00109	0.00176	CcSEcCtD
Methylergometrine—Rash—Pilocarpine—glaucoma	0.00108	0.00176	CcSEcCtD
Methylergometrine—Dermatitis—Pilocarpine—glaucoma	0.00108	0.00176	CcSEcCtD
Methylergometrine—Nausea—Dorzolamide—glaucoma	0.00108	0.00176	CcSEcCtD
Methylergometrine—Headache—Pilocarpine—glaucoma	0.00108	0.00175	CcSEcCtD
Methylergometrine—Nausea—Travoprost—glaucoma	0.00108	0.00175	CcSEcCtD
Methylergometrine—Paraesthesia—Betaxolol—glaucoma	0.00107	0.00175	CcSEcCtD
Methylergometrine—Dyspnoea—Betaxolol—glaucoma	0.00107	0.00173	CcSEcCtD
Methylergometrine—Nausea—Brinzolamide—glaucoma	0.00106	0.00173	CcSEcCtD
Methylergometrine—Palpitations—Timolol—glaucoma	0.00106	0.00172	CcSEcCtD
Methylergometrine—Hypertension—Timolol—glaucoma	0.00103	0.00168	CcSEcCtD
Methylergometrine—Nausea—Pilocarpine—glaucoma	0.00102	0.00166	CcSEcCtD
Methylergometrine—Chest pain—Timolol—glaucoma	0.00102	0.00166	CcSEcCtD
Methylergometrine—Anaphylactic shock—Timolol—glaucoma	0.000977	0.00159	CcSEcCtD
Methylergometrine—Nervous system disorder—Timolol—glaucoma	0.000958	0.00156	CcSEcCtD
Methylergometrine—Hyperhidrosis—Timolol—glaucoma	0.000945	0.00153	CcSEcCtD
Methylergometrine—Diarrhoea—Clonidine—glaucoma	0.00094	0.00153	CcSEcCtD
Methylergometrine—Hypotension—Timolol—glaucoma	0.000913	0.00148	CcSEcCtD
Methylergometrine—Dizziness—Clonidine—glaucoma	0.000908	0.00148	CcSEcCtD
Methylergometrine—Paraesthesia—Timolol—glaucoma	0.000877	0.00143	CcSEcCtD
Methylergometrine—Vomiting—Clonidine—glaucoma	0.000873	0.00142	CcSEcCtD
Methylergometrine—Dyspnoea—Timolol—glaucoma	0.000871	0.00142	CcSEcCtD
Methylergometrine—Rash—Clonidine—glaucoma	0.000866	0.00141	CcSEcCtD
Methylergometrine—Dermatitis—Clonidine—glaucoma	0.000865	0.00141	CcSEcCtD
Methylergometrine—Headache—Clonidine—glaucoma	0.000861	0.0014	CcSEcCtD
Methylergometrine—Diarrhoea—Betaxolol—glaucoma	0.000818	0.00133	CcSEcCtD
Methylergometrine—Nausea—Clonidine—glaucoma	0.000816	0.00133	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Timolol—glaucoma	0.000799	0.0013	CcSEcCtD
Methylergometrine—Dizziness—Betaxolol—glaucoma	0.000791	0.00129	CcSEcCtD
Methylergometrine—Abdominal pain—Timolol—glaucoma	0.000772	0.00126	CcSEcCtD
Methylergometrine—Vomiting—Betaxolol—glaucoma	0.00076	0.00124	CcSEcCtD
Methylergometrine—Rash—Betaxolol—glaucoma	0.000754	0.00123	CcSEcCtD
Methylergometrine—Dermatitis—Betaxolol—glaucoma	0.000753	0.00122	CcSEcCtD
Methylergometrine—Headache—Betaxolol—glaucoma	0.000749	0.00122	CcSEcCtD
Methylergometrine—Nausea—Betaxolol—glaucoma	0.00071	0.00115	CcSEcCtD
Methylergometrine—Diarrhoea—Timolol—glaucoma	0.000668	0.00109	CcSEcCtD
Methylergometrine—Dizziness—Timolol—glaucoma	0.000646	0.00105	CcSEcCtD
Methylergometrine—Vomiting—Timolol—glaucoma	0.000621	0.00101	CcSEcCtD
Methylergometrine—Rash—Timolol—glaucoma	0.000616	0.001	CcSEcCtD
Methylergometrine—Dermatitis—Timolol—glaucoma	0.000615	0.001	CcSEcCtD
Methylergometrine—Headache—Timolol—glaucoma	0.000612	0.000995	CcSEcCtD
Methylergometrine—Nausea—Timolol—glaucoma	0.00058	0.000943	CcSEcCtD
Methylergometrine—HTR1F—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000248	0.00334	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—OPN4—glaucoma	0.00024	0.00324	CbGpPWpGaD
Methylergometrine—HTR1E—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000234	0.00316	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—OPN4—glaucoma	0.000226	0.00305	CbGpPWpGaD
Methylergometrine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	0.000225	0.00304	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—OPN4—glaucoma	0.000219	0.00295	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—OPN4—glaucoma	0.000218	0.00294	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR ligand binding—EDN1—glaucoma	0.000216	0.00292	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—PTGFR—glaucoma	0.000216	0.00292	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—BDNF—glaucoma	0.000211	0.00285	CbGpPWpGaD
Methylergometrine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.00021	0.00283	CbGpPWpGaD
Methylergometrine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000207	0.0028	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—OPN4—glaucoma	0.000206	0.00279	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—OPN4—glaucoma	0.000205	0.00277	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR ligand binding—EDN1—glaucoma	0.000204	0.00275	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—PTGFR—glaucoma	0.000204	0.00275	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—HEYL—glaucoma	0.000203	0.00275	CbGpPWpGaD
Methylergometrine—HTR2C—G alpha (q) signalling events—EDN1—glaucoma	0.000203	0.00274	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—IL1A—glaucoma	0.000203	0.00274	CbGpPWpGaD
Methylergometrine—DRD1—Circadian rythm related genes—FAS—glaucoma	0.000199	0.00268	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—PTGFR—glaucoma	0.000197	0.00266	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—PTGFR—glaucoma	0.000196	0.00265	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—OPN4—glaucoma	0.000193	0.00261	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—SMO—glaucoma	0.000193	0.0026	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—HEYL—glaucoma	0.000192	0.00259	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR ligand binding—C3—glaucoma	0.000189	0.00255	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—NGF—glaucoma	0.000187	0.00253	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—NR3C1—glaucoma	0.000187	0.00252	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—PTGFR—glaucoma	0.000186	0.00251	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—LRP12—glaucoma	0.000186	0.00251	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—PTGFR—glaucoma	0.000185	0.0025	CbGpPWpGaD
Methylergometrine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	0.000182	0.00245	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—SMO—glaucoma	0.000182	0.00245	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR ligand binding—C3—glaucoma	0.000178	0.0024	CbGpPWpGaD
Methylergometrine—HTR2A—G alpha (q) signalling events—EDN1—glaucoma	0.000176	0.00238	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—OPN4—glaucoma	0.000176	0.00237	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—LRP12—glaucoma	0.000175	0.00236	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—PTGFR—glaucoma	0.000174	0.00235	CbGpPWpGaD
Methylergometrine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.00017	0.0023	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—SMO—glaucoma	0.000168	0.00227	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—OPN4—glaucoma	0.000168	0.00227	CbGpPWpGaD
Methylergometrine—HTR2B—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000167	0.00225	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—SMO—glaucoma	0.000159	0.00214	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—PTGFR—glaucoma	0.000158	0.00214	CbGpPWpGaD
Methylergometrine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	0.000158	0.00213	CbGpPWpGaD
Methylergometrine—DRD1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000157	0.00212	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—SMO—glaucoma	0.000155	0.0021	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—RPTOR—glaucoma	0.000154	0.00208	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—OPN4—glaucoma	0.000153	0.00206	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—PTGFR—glaucoma	0.000151	0.00204	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—LRP12—glaucoma	0.00015	0.00202	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—NCK2—glaucoma	0.000149	0.00201	CbGpPWpGaD
Methylergometrine—HTR2B—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000146	0.00197	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—RPTOR—glaucoma	0.000145	0.00196	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—NCK2—glaucoma	0.000141	0.0019	CbGpPWpGaD
Methylergometrine—DRD1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000137	0.00186	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—PTGFR—glaucoma	0.000137	0.00185	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—SMO—glaucoma	0.000135	0.00182	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000135	0.00182	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—LRP12—glaucoma	0.00013	0.00176	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—OPN4—glaucoma	0.000129	0.00174	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—EDN1—glaucoma	0.000127	0.00171	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—HDAC9—glaucoma	0.000127	0.00171	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—EDN1—glaucoma	0.000122	0.00165	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—OPN4—glaucoma	0.000121	0.00164	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—EDN1—glaucoma	0.00012	0.00162	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—HDAC9—glaucoma	0.00012	0.00162	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—HEYL—glaucoma	0.00012	0.00161	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000118	0.00159	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000117	0.00158	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PTGFR—glaucoma	0.000116	0.00156	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—EDN1—glaucoma	0.000115	0.00155	CbGpPWpGaD
Methylergometrine—CYP3A4—Biological oxidations—GSTT1—glaucoma	0.000113	0.00153	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—HEYL—glaucoma	0.000113	0.00152	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—C3—glaucoma	0.000111	0.0015	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—EDN1—glaucoma	0.000111	0.0015	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PTGFR—glaucoma	0.000109	0.00147	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—C3—glaucoma	0.000107	0.00144	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—C3—glaucoma	0.000105	0.00141	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—EDN1—glaucoma	0.000105	0.00141	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—OPN4—glaucoma	0.000104	0.0014	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—EDN1—glaucoma	0.000102	0.00138	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000102	0.00138	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—C3—glaucoma	0.000101	0.00136	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—SMO—glaucoma	9.93e-05	0.00134	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—SMO—glaucoma	9.89e-05	0.00133	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—C3—glaucoma	9.68e-05	0.00131	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—HEYL—glaucoma	9.65e-05	0.0013	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—SMO—glaucoma	9.36e-05	0.00126	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PTGFR—glaucoma	9.34e-05	0.00126	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—SMO—glaucoma	9.32e-05	0.00126	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—C3—glaucoma	9.13e-05	0.00123	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—NTRK2—glaucoma	9.08e-05	0.00123	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—RPTOR—glaucoma	9.06e-05	0.00122	CbGpPWpGaD
Methylergometrine—CYP3A4—Biological oxidations—CYP1B1—glaucoma	9.04e-05	0.00122	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—OPN4—glaucoma	9.01e-05	0.00122	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—VEGFA—glaucoma	8.95e-05	0.00121	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—C3—glaucoma	8.95e-05	0.00121	CbGpPWpGaD
Methylergometrine—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	8.92e-05	0.0012	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—EDN1—glaucoma	8.9e-05	0.0012	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NCK2—glaucoma	8.78e-05	0.00119	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—NTRK2—glaucoma	8.57e-05	0.00116	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—RPTOR—glaucoma	8.55e-05	0.00115	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—HEYL—glaucoma	8.38e-05	0.00113	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NCK2—glaucoma	8.28e-05	0.00112	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PTGFR—glaucoma	8.11e-05	0.0011	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—SMO—glaucoma	7.97e-05	0.00108	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CA5A—glaucoma	7.95e-05	0.00107	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—NARFL—glaucoma	7.95e-05	0.00107	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—NGFR—glaucoma	7.79e-05	0.00105	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—C3—glaucoma	7.77e-05	0.00105	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—TNF—glaucoma	7.67e-05	0.00104	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—HDAC9—glaucoma	7.46e-05	0.00101	CbGpPWpGaD
Methylergometrine—DRD1—Circadian rythm related genes—TP53—glaucoma	7.43e-05	0.001	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—NTRK1—glaucoma	7.4e-05	0.001	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—NGFR—glaucoma	7.35e-05	0.000992	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—RPTOR—glaucoma	7.31e-05	0.000987	CbGpPWpGaD
Methylergometrine—CYP3A4—Biological oxidations—GSTM1—glaucoma	7.23e-05	0.000976	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—EDN1—glaucoma	7.18e-05	0.000969	CbGpPWpGaD
Methylergometrine—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	7.13e-05	0.000962	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NCK2—glaucoma	7.08e-05	0.000956	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—HDAC9—glaucoma	7.04e-05	0.00095	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—NTRK1—glaucoma	6.98e-05	0.000943	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—SMO—glaucoma	6.93e-05	0.000935	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CDKN2B—glaucoma	6.82e-05	0.000921	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—EDN1—glaucoma	6.77e-05	0.000914	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—EDN1—glaucoma	6.55e-05	0.000884	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—EDN1—glaucoma	6.52e-05	0.00088	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CDKN2B—glaucoma	6.43e-05	0.000869	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—RPTOR—glaucoma	6.35e-05	0.000857	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—C3—glaucoma	6.27e-05	0.000847	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—EDN1—glaucoma	6.17e-05	0.000834	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NCK2—glaucoma	6.15e-05	0.00083	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—EDN1—glaucoma	6.15e-05	0.00083	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—HDAC9—glaucoma	6.02e-05	0.000813	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—NGF—glaucoma	6.01e-05	0.000812	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—C3—glaucoma	5.91e-05	0.000798	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—SMO—glaucoma	5.84e-05	0.000789	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—EDN1—glaucoma	5.79e-05	0.000782	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—C3—glaucoma	5.72e-05	0.000772	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—C3—glaucoma	5.69e-05	0.000769	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—NGF—glaucoma	5.67e-05	0.000766	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—SMO—glaucoma	5.51e-05	0.000744	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—C3—glaucoma	5.39e-05	0.000728	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—C3—glaucoma	5.37e-05	0.000725	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NTRK2—glaucoma	5.34e-05	0.000721	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—APOE—glaucoma	5.32e-05	0.000719	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CAV1—glaucoma	5.27e-05	0.000712	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—EDN1—glaucoma	5.26e-05	0.00071	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—HDAC9—glaucoma	5.23e-05	0.000706	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—C3—glaucoma	5.06e-05	0.000683	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NTRK2—glaucoma	5.04e-05	0.00068	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—EDN1—glaucoma	5.03e-05	0.000679	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—APOE—glaucoma	5.02e-05	0.000678	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—FN1—glaucoma	5.02e-05	0.000678	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CAV1—glaucoma	4.98e-05	0.000672	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—BAD—glaucoma	4.96e-05	0.00067	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—FN1—glaucoma	4.74e-05	0.000639	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—SMO—glaucoma	4.71e-05	0.000636	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—BAD—glaucoma	4.68e-05	0.000632	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—C3—glaucoma	4.59e-05	0.00062	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NGFR—glaucoma	4.58e-05	0.000619	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—EDN1—glaucoma	4.57e-05	0.000617	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—C3—glaucoma	4.39e-05	0.000593	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NTRK1—glaucoma	4.35e-05	0.000588	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NGFR—glaucoma	4.32e-05	0.000584	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NTRK2—glaucoma	4.31e-05	0.000582	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NTRK1—glaucoma	4.11e-05	0.000554	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—SMO—glaucoma	4.09e-05	0.000552	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CDKN2B—glaucoma	4.01e-05	0.000542	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—C3—glaucoma	3.99e-05	0.000539	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—NOS3—glaucoma	3.99e-05	0.000539	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CA1—glaucoma	3.88e-05	0.000524	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—EDN1—glaucoma	3.85e-05	0.00052	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CDKN2B—glaucoma	3.78e-05	0.000511	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—NOS3—glaucoma	3.76e-05	0.000508	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CTSA—glaucoma	3.76e-05	0.000508	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NTRK2—glaucoma	3.74e-05	0.000505	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NGFR—glaucoma	3.7e-05	0.000499	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—EDN1—glaucoma	3.63e-05	0.00049	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CA2—glaucoma	3.55e-05	0.00048	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NGF—glaucoma	3.54e-05	0.000478	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NTRK1—glaucoma	3.51e-05	0.000474	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CDKN1B—glaucoma	3.45e-05	0.000467	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—C3—glaucoma	3.36e-05	0.000454	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NGF—glaucoma	3.34e-05	0.000451	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CDKN1B—glaucoma	3.26e-05	0.00044	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CDKN2B—glaucoma	3.24e-05	0.000437	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NGFR—glaucoma	3.21e-05	0.000434	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—MMP9—glaucoma	3.2e-05	0.000432	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—C3—glaucoma	3.17e-05	0.000428	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—APOE—glaucoma	3.13e-05	0.000423	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—EDN1—glaucoma	3.11e-05	0.000419	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CAV1—glaucoma	3.1e-05	0.000419	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NTRK1—glaucoma	3.05e-05	0.000412	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—MMP9—glaucoma	3.02e-05	0.000408	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—APOE—glaucoma	2.95e-05	0.000399	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—FN1—glaucoma	2.95e-05	0.000399	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CAV1—glaucoma	2.93e-05	0.000395	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—BAD—glaucoma	2.92e-05	0.000394	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—VEGFA—glaucoma	2.87e-05	0.000388	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NGF—glaucoma	2.85e-05	0.000385	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CDKN2B—glaucoma	2.81e-05	0.00038	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—FN1—glaucoma	2.78e-05	0.000376	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—BAD—glaucoma	2.75e-05	0.000372	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—C3—glaucoma	2.71e-05	0.000366	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—VEGFA—glaucoma	2.71e-05	0.000366	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—EDN1—glaucoma	2.7e-05	0.000364	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—APOE—glaucoma	2.53e-05	0.000341	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CAV1—glaucoma	2.5e-05	0.000338	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—TXN—glaucoma	2.5e-05	0.000338	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NGF—glaucoma	2.48e-05	0.000335	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—FN1—glaucoma	2.38e-05	0.000322	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—C3—glaucoma	2.36e-05	0.000318	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—BAD—glaucoma	2.35e-05	0.000318	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NOS3—glaucoma	2.35e-05	0.000317	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NOS3—glaucoma	2.21e-05	0.000299	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—APOE—glaucoma	2.19e-05	0.000296	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CAV1—glaucoma	2.17e-05	0.000293	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—TP53—glaucoma	2.17e-05	0.000293	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—FN1—glaucoma	2.07e-05	0.000279	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—TP53—glaucoma	2.05e-05	0.000277	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—BAD—glaucoma	2.04e-05	0.000276	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CDKN1B—glaucoma	2.03e-05	0.000274	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GSTT1—glaucoma	1.94e-05	0.000262	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CDKN1B—glaucoma	1.92e-05	0.000259	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NOS3—glaucoma	1.89e-05	0.000256	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MMP9—glaucoma	1.88e-05	0.000254	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MMP9—glaucoma	1.77e-05	0.00024	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—VEGFA—glaucoma	1.69e-05	0.000228	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NOS3—glaucoma	1.64e-05	0.000222	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CDKN1B—glaucoma	1.64e-05	0.000221	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—VEGFA—glaucoma	1.59e-05	0.000215	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CYP1B1—glaucoma	1.55e-05	0.000209	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ABCA1—glaucoma	1.55e-05	0.000209	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MMP9—glaucoma	1.52e-05	0.000205	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CDKN1B—glaucoma	1.42e-05	0.000192	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—VEGFA—glaucoma	1.36e-05	0.000184	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MMP9—glaucoma	1.32e-05	0.000178	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TP53—glaucoma	1.28e-05	0.000172	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GSTM1—glaucoma	1.24e-05	0.000167	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TP53—glaucoma	1.2e-05	0.000163	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—VEGFA—glaucoma	1.18e-05	0.00016	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—MTHFR—glaucoma	1.09e-05	0.000147	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TP53—glaucoma	1.03e-05	0.000139	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—APOE—glaucoma	1.02e-05	0.000137	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CAV1—glaucoma	1.01e-05	0.000136	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TP53—glaucoma	8.95e-06	0.000121	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—NOS3—glaucoma	7.62e-06	0.000103	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PTGS2—glaucoma	6.97e-06	9.41e-05	CbGpPWpGaD
